Arrowpoint Asset Management »

Celldex Therapeutics shares owned by Arrowpoint Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Arrowpoint Asset Management from 13F filings

Historical chart of Arrowpoint Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Arrowpoint Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $647k 25k 25.87
2025-06-30 $509k 25k 20.35
2025-03-31 $454k 25k 18.15
2024-12-31 $632k 25k 25.27
2024-09-30 $850k 25k 33.99
2024-06-30 $925k 25k 37.01
2024-03-31 $1.0M 25k 41.97